HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.

Abstract
The aim of this study was to compare pertussis-specific humoral and cellular immunity in children 5 years after a primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine (DTaP-HBV; InfanrixHepB; SmithKline Beecham) with immunity after natural infection. The subjects were 38 children aged 5 to 6 years who received DTaP-HBV at 3, 5, and 11 months of life and 21 subjects of similar ages and sex who acquired pertussis in the first year of life. Immunoglobulin G (IgG) antibody titers against Bordetella pertussis antigens, peripheral blood mononuclear cell-specific proliferation, and the secretion of cytokines were evaluated. After 5 years, only a small proportion of vaccinated and infected children had significant specific concentrations of IgG in serum against all three B. pertussis antigens, and T-cell responses persisted in a minority of subjects. A preferential type 1 cytokine response with the secretion of gamma interferon was observed in the pertussis group, whereas a type 2 skewed response was observed in the vaccinated children; however, the quantitative differences in the cytokines produced by DTaP-HBV and natural infection were minimal. In conclusion, our results show that the immune responses induced by primary pertussis vaccination are qualitatively and quantitatively similar to those seen in children who recovered from natural infection and highlight the need for booster immunization with pertussis vaccines in order to maintain adequate levels of a specific immune response to B. pertussis.
AuthorsS Esposito, T Agliardi, A Giammanco, G Faldella, A Cascio, S Bosis, O Friscia, M Clerici, N Principi
JournalInfection and immunity (Infect Immun) Vol. 69 Issue 7 Pg. 4516-20 (Jul 2001) ISSN: 0019-9567 [Print] United States
PMID11401994 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Haemophilus Vaccines
  • Hepatitis B Vaccines
  • Interleukin-2
  • Interleukin-5
  • Vaccines, Combined
  • diphtheria-tetanus-acellular pertussis-Hib-hepatitis B vaccine
  • Interleukin-4
  • Interferon-gamma
Topics
  • Antibodies, Bacterial (blood)
  • Bordetella pertussis (immunology)
  • Cell Division
  • Child
  • Child, Preschool
  • Diphtheria-Tetanus-Pertussis Vaccine (immunology)
  • Female
  • Haemophilus Vaccines (immunology)
  • Hepatitis B Vaccines (immunology)
  • Humans
  • Interferon-gamma (biosynthesis)
  • Interleukin-2 (biosynthesis)
  • Interleukin-4 (biosynthesis)
  • Interleukin-5 (biosynthesis)
  • Lymphocytes (cytology, immunology)
  • Male
  • Single-Blind Method
  • Time Factors
  • Vaccination
  • Vaccines, Combined (immunology)
  • Whooping Cough (blood, immunology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: